COVID-19 Research Paper Volume 14, Issue 1 pp 73—108
Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration
Figure 4. Establishment and validation of the prognostic nomogram. (A, B) Univariate and multivariate Cox regression analysis of clinicopathologic variables and TMPRSS2 in lung cancer. (C) Nomogram for predicting the 1-, 3-, and 5-year OS of lung cancer patients. (D) Calibration curves of 1-, 3-, and 5-year OS of lung cancer patients.